Roche nabs FDA clearance for Alzheimer’s biomarker blood test
Roche, which currently has investigational Alzheimer’s disease drug trontinemab in phase 3 trials, has secured FDA clearance of its blood-based biomarker test for the condition. The minimally invasive Elecsys pTau181…








